NCT07224906Recruiting
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Observational Study of the HemoCept Device During Right Heart Catheterization at Boulder Heart
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 31 Oct 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- HemoCept Inc.
- NCT number
- NCT07224906
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Dec 2025 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Who the study is looking for
- Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
- Subjects can be any gender but must be age 18 or older.
- Subject is able and willing to provide informed consent and HIPAA authorization.
- Subject is able and willing to meet all study requirements.
- Scheduled for a diagnostic right heart catheterization (RHC-only or combined RHC+LHC; left-heart-only procedures are not eligible)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Boulder Heart Coordinator of this site? Confirm its status | Boulder | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.